StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Biogen (BIIB) PT Lowered to $400 at BofA Securities
July 16, 2021 8:25 AM
BofA Securities analyst Geoff Meacham ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst PT Change
Next Articles
Biogen (BIIB) PT Lowered to $453 at Morgan Stanley
July 16, 2021 4:06 AM
Expert Panel Unanimously Decides Biogen's (BIIB) Aduhelm Offers no Patient Benefit
July 15, 2021 5:38 PM
Biogen Alzheimer's drug hits roadblocks with some hospitals, insurers
July 15, 2021 3:03 PM
UnitedHealth says needs more information to decide on coverage policy for Biogen's Alzheimer's drug - CEO
July 15, 2021 9:44 AM
UnitedHealth (UNH) Looking for Medicare Guidance on Aduhelm Coverage, Still Developing Policy on Biogen (BIIB) Alzheimer's Drug - Bloomberg
July 15, 2021 9:30 AM
Cleveland Clinic Bans Biogen's (BIIB) Aduhelm, Will Others Follow Suit?
July 15, 2021 8:02 AM
